|
biomedicina slovenica |
id=45284 : 1
-
Therasse P; Mauriac L; Welnicka M; Bruning P; Čufer T; Tomiak E; Curran D; Ramirez A; Koopmanschap M; Piccart M
An EORTC-NCIC-SAKK neoadjuvant randomized phase III study comparing CEF (5FU, epirubicin, cyclophosphamide) vs dose intensified EC+G-CSF (filgrastim) in locally advanced breast cancer (LABC): updated results including quality of life
1998 ►
Nova poizvedba
Pripombe
Na vrh strani
Inštitut za biostatistiko in medicinsko informatiko